Suspected adverse reactions associated with herbal products used for weight loss: a case series reported to the Italian National Institute of Health Annabella VitaloneFrancesca Menniti-IppolitoGabriela Mazzanti Review Article 18 January 2011 Pages: 215 - 224
Power estimation using a population pharmacokinetics model with optimal design by clinical trial simulations: application in pharmacokinetic drug–drug interaction studies Shuying YangMisba Beerahee Clinical Trial 02 December 2010 Pages: 225 - 233
EGFR-targeted therapies combined with chemotherapy for treating advanced non-small-cell lung cancer: a meta-analysis Peng ChenLong WangZui Zou Clinical Trial 05 January 2011 Pages: 235 - 243
Three years of paediatric regulation in the European Union Thorsten M. OlskiSimona F. LampusAgnes Saint Raymond Special Article 01 February 2011 Pages: 245 - 252
Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients Maud BergeRomain GuillemainMarie-Anne Loriot Pharmacogenetics 31 October 2010 Pages: 253 - 260
CYP2C19-guided design of a proton pump inhibitor dose regimen to avoid the need for pharmacogenetic individualisation in H. pylori eradication Michael B. WardDavid J. R. Foster Pharmacogenetics 16 November 2010 Pages: 261 - 266
Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers Anny FortinRoger K. VerbeeckFrans H. Jansen Pharmacokinetics and Disposition 15 October 2010 Pages: 267 - 275
Lack of a pharmacokinetic interaction between steady-state tipranavir/ritonavir and single-dose valacyclovir in healthy volunteers John P. SaboXiuyu (Julie) CongThomas R. MacGregor Pharmacokinetics and Disposition 12 October 2010 Pages: 277 - 281
Adverse events following immunization in children: retrospective analysis of spontaneous reports over a decade Lise AagaardErik Wind HansenEbba Holme Hansen Pharmacoepidemiology and Prescription 16 November 2010 Pages: 283 - 288
Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy Giovanni CorraoSilvana Antonietta RomioMarina Scavini Pharmacoepidemiology and Prescription 19 November 2010 Pages: 289 - 299
Primary-care prescribing of anti-osteoporotic-type medications following hospitalisation for fractures Bernie M. McGowanKath BennettMiriam C. Casey Pharmacoepidemiology and Prescription 23 November 2010 Pages: 301 - 308
Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial Qian ZhangClaire Bal-dit-SollierIsabelle Mahé Short Communication 30 December 2010 Pages: 309 - 314
Drug-to-drug interaction between sodium valproate and trihexyphenidyl in a child with extrapyramidal cerebral palsy and epilepsy Marta De RinaldisLeonarda GennaroAntonio Trabacca Letter to the Editors 20 October 2010 Pages: 315 - 316
Cephalosporin-induced recurrent aplastic anemia Jimin HanHyojeong LeeTae-Bum Kim Letter to the Editors Open access 12 October 2010 Pages: 317 - 318
Earlier discovery of pregabalin’s dependence potential might have been possible Ola CasterI. Ralph EdwardsMarie Lindquist Letter to the Editors 23 October 2010 Pages: 319 - 320